Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Int. j. morphol ; 42(1): 173-184, feb. 2024.
Artigo em Inglês | LILACS | ID: biblio-1528836

RESUMO

SUMMARY: Calcium-activated chloride channel regulator 1 (CLCA1) is associated with cancer progression. The expression and immunologic function of CLCA1 in stomach adenocarcinoma (STAD) remain unclear. In this investigation, the expression of CLCA1 in STAD tissues and its involvement in the progression and immune response of STAD were examined using databases such as cBioPortal, TISIDB, and UALCAN. In order to validate the expression level of CLCA1 protein in gastric adenocarcinoma, thirty clinical tissue specimens were gathered for immunohistochemical staining. The findings indicated a downregulation of CLCA1 in STAD patients, which was correlated with race, age, cancer grade, Helicobacter pylori infection, and molecular subtype. Through the examination of survival analysis, it was identified that diminished levels of CLCA1 within gastric cancer cases were linked to decreased periods of post-progression survival (PPS), overall survival (OS), and first progression (FP) (P<0.05). The CLCA1 mutation rate was lower in STAD, but the survival rate was higher in the variant group. The correlation between the expression level of CLCA1 and the levels of immune infiltrating cells in STAD, as well as the immune activating molecules, immunosuppressive molecules, MHC molecules, chemokines, and their receptor molecules, was observed. Gene enrichment analysis revealed that CLCA1 may be involved in STAD progression through systemic lupus erythematosus (SLE), proteasome, cell cycle, pancreatic secretion, and PPAR signaling pathways. In summary, CLCA1 is anticipated to function as a prognostic marker for patients with STAD and is linked to the immunization of STAD.


El regulador 1 del canal de cloruro activado por calcio (CLCA1) está asociado con la progresión del cáncer. La expresión y la función inmunológica de CLCA1 en el adenocarcinoma de estómago (STAD) aún no están claras. En esta investigación, se examinó la expresión de CLCA1 en tejidos STAD y su participación en la progresión y respuesta inmune de STAD utilizando bases de datos como cBioPortal, TISIDB y UALCAN. Para validar el nivel de expresión de la proteína CLCA1 en el adenocarcinoma gástrico, se recolectaron treinta muestras de tejido clínico para tinción inmunohistoquímica. Los hallazgos indicaron una regulación negativa de CLCA1 en pacientes con STAD, que se correlacionó con la raza, la edad, el grado del cáncer, la infección por Helicobacter pylori y el subtipo molecular. Mediante el examen del análisis de supervivencia, se identificó que los niveles reducidos de CLCA1 en los casos de cáncer gástrico estaban relacionados con períodos reducidos de supervivencia posterior a la progresión (PPS), supervivencia general (OS) y primera progresión (FP) (P <0,05). La tasa de mutación CLCA1 fue menor en STAD, pero la tasa de supervivencia fue mayor en el grupo variante. Se observó la correlación entre el nivel de expresión de CLCA1 y los niveles de células inmunes infiltrantes en STAD, así como las moléculas activadoras inmunes, moléculas inmunosupresoras, moléculas MHC, quimiocinas y sus moléculas receptoras. El análisis de enriquecimiento genético reveló que CLCA1 puede estar involucrado en la progresión de STAD a través del lupus eritematoso sistémico (LES), el proteasoma, el ciclo celular, la secreción pancreática y las vías de señalización de PPAR. En resumen, se prevé que CLCA1 funcione como un marcador de pronóstico para pacientes con STAD y está vinculado a la inmunización de STAD.


Assuntos
Humanos , Neoplasias Gástricas/metabolismo , Adenocarcinoma/metabolismo , Canais de Cloreto/metabolismo , Prognóstico , Neoplasias Gástricas/imunologia , Imuno-Histoquímica , Adenocarcinoma/imunologia , Biomarcadores Tumorais , Análise de Sobrevida , Canais de Cloreto/genética , Canais de Cloreto/imunologia , Biologia Computacional , Mutação
2.
Sheng Li Xue Bao ; 74(5): 705-714, 2022 Oct 25.
Artigo em Chinês | MEDLINE | ID: mdl-36319094

RESUMO

The purpose of this study was to investigate the effects of acute fear stress on the spatial memory and neuronal plasticity of medial prefrontal cortex (mPFC) neurons in mice, and to elucidate the mechanisms underlying mPFC plasticity and post-stress memory regulation. Male C57BL/6 mice (6 weeks old) were randomly divided into control group and stress group. Foot shock stress was applied to establish an acute fear stress model. Changes in spatial memory were examined by the Morris water maze test, and the dynamic changes in the spike encoding of pyramidal neurons and GABAergic neurons in the prelimbic cortex (PrL) and infralimbic cortex (IL) of mPFC were detected by whole-cell recording. The results showed that acute fear stress significantly enhanced the percentage of freezing and the number of freezing, reduced the average speed, decreased the escape latency during acquisition phase, extended the probing time in the first quadrant and shortened the probing time in the third quadrant during probe trial, increased inter-spike interval, energy barrier and absolute refractory period of GABAergic neurons in the PrL and pyramidal neurons in the IL, while decreased inter-spike interval, energy barrier and absolute refractory period of pyramidal neurons in the PrL and GABAergic neurons in the IL. These results suggest that acute fear stress can enhance the spatial memory of mice, elevate the excitability and function of the PrL, while deteriorate the excitability and function of the IL, and the underlying mechanism may involve the role of mPFC microcircuitry plasticity in spatial memory after stress.


Assuntos
Plasticidade Neuronal , Memória Espacial , Animais , Masculino , Camundongos , Medo , Camundongos Endogâmicos C57BL , Córtex Pré-Frontal
3.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi ; 38(1): 24-31, 2022 Jan.
Artigo em Chinês | MEDLINE | ID: mdl-35078572

RESUMO

Objective To analyze the correlation between the expression of TOP2A gene and the proportion of CD4+T cells in hepatocellular carcinoma (HCC) and its clinical prognostic significance. Methods The expression of TOP2A mRNA in normal liver tissues and HCC tissues and its significance for survival and prognosis of HCC patients were analyzed by BioGPS, GEPIA and Kaplan-Meier Plotter databases. The coexpression gene of TOP2A and its GO function were analyzed using GENE and Metascape databases, along with the KEGG pathway enrichment analysis. The correlation between TOP2A and microsatellite instability (MSI) and DNA repair gene was analyzed by Sangerbox database. Then, the correlation between TOP2A gene and CD4+ T cells and various immune cells was analyzed by TISIDB and TIMER database, and analysis was also performed regarding the effect of CD4+ T cells on the survival and prognosis of HCC patients. Results TOP2A mRNA is not significantly expressed in normal liver tissues and CD4+ T cells, but is significantly expressed in HCC tissue, which is not conducive to the survival and prognosis of patients. The GO function of TOP2A coexpression gene is mainly enriched in cell mitosis and cell proliferation, while KEGG is mainly enriched in cell cycle and platinum drug resistance pathway. The expression of TOP2A is positively correlated with MSI, MSH2 and MSH6 of DNA repair gene, the purity of tumor cells and the numbers of various immune cells. All kinds of immune cells reported certain copy number variation in HCC, but only the numbers of CD4+ T cells showed a significant effect on the survival and prognosis of HCC patients. Conclusion There is a significant positive correlation between the expression of TOP2A mRNA and the number of CD4+T cells in HCC, which is not conducive to the survival and prognosis of HCC patients.


Assuntos
Carcinoma Hepatocelular , Neoplasias Hepáticas , Biomarcadores Tumorais , Linfócitos T CD4-Positivos , Carcinoma Hepatocelular/genética , Variações do Número de Cópias de DNA , Expressão Gênica , Humanos , Neoplasias Hepáticas/genética , Prognóstico , Linfócitos T
4.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi ; 35(10): 903-909, 2019 Oct.
Artigo em Chinês | MEDLINE | ID: mdl-31814567

RESUMO

Objective To investigate the expression of C-C motif chemokine ligand 23 (CCL23) in hepatocellular carcinoma (HCC) and its clinical significance for survival and prognosis. Methods GEPIA, HCCDB, MetaScape, TIMER, TISIDB, Kaplan-Meier Plotter and other online databases were used to analyze the expression level of CCL23 in HCC, the functional notes of co-expression gene and its gene ontology (GO), the enrichment of Kyoto gene and genome encyclopedia (KEGG), the correlation between tumor cell purity, the expression of CCL23 in immune cells and its significance for survival and prognosis of patients. Results The expression of CCL23 in all stages of HCC was negatively correlated with the purity of HCC tumor cells. The short prognosis of HCC patients with low expression of CCL23 was poor. The GO function and KEGG pathway of CCL23 co-expressed gene in HCC were mainly enriched in immune cell activation and complement system activation. CCL23 was the strongest chemokine factor in HCC, and it could bind to multiple receptors including CC chemokine receptor 1 (CCR1), CCR2, CCR7 and CXC chemokine receptor 6 (CXCR6) to exert chemokine effect on immune cells, among which CD8+ T cells and macrophages have the most obvious chemokine effect. Conclusion The low expression of CCL23 in HCC tissue is not conducive to the development of anti-tumor immune defense in HCC patients and significantly shortens the survival of HCC patients.


Assuntos
Carcinoma Hepatocelular/genética , Quimiocinas CC/genética , Neoplasias Hepáticas/genética , Linfócitos T CD8-Positivos , Carcinoma Hepatocelular/imunologia , Biologia Computacional , Humanos , Neoplasias Hepáticas/imunologia , Macrófagos , Receptores CCR1/metabolismo , Receptores CCR2/metabolismo , Receptores CCR7/metabolismo , Receptores CXCR6/metabolismo
5.
Nan Fang Yi Ke Da Xue Xue Bao ; 38(5): 505-510, 2018 May 20.
Artigo em Chinês | MEDLINE | ID: mdl-29891444

RESUMO

OBJECTIVE: To investigate the tumor-suppressing effect of microRNA-218 (miR-218) in osteosarcoma (OS) and explore its molecular mechanism. METHODS: We examined the expression levels of miR-218 in 68 pairs of OS and adjacent tissue samples using qRT-PCR. Cultured human OS cell line Saos-2 was transfected with miR-218 mimics or anti-miR-218 mimics, and the cell apoptosis was assessed using CCK-8 assay, annexin V-FITC staining and Western blotting. We also analyzed the potential functional targets of miR-218 in Saos-2 cells using luciferase assay, qRT-PCR and Western blotting. RESULTS: The expression level of miR-218 was lowered by at least 8 folds in OS tissues as compared with the adjacent tissues. In cultured Saos-2 cells, transfection with miR-218 mimics for 24, 36, and 48 h resulted in a significant reduction in the cell viability, while transfection with anti-miR-218 mimics significantly increased the cell viability. The cells transfected with miR-218 mimics showed an obviously enhanced expression of cleaved poly(ADP-ribose) polymerase (C-PARP) as compared with the cells transfected with anti-miR-218 mimics and the control cells. Flow cytometry demonstrated obviously increased apoptosis of the cells following miR-218 mimics transfection. We identified the oncogene B lymphoma mouse Moloney leukemia virus insertion region 1 (BMI-1) as a specific target of miR-218 in Saos-2 cells. BMI-1 expressions at both the mRNA and protein levels were significantly reduced in Saos-2 cells overexpressing miR-218 but increased in the cells with miR-218 knockdown as compared to the control cells. Luciferase reporter assay indicated that miR-218 directly inhibited the expression of BMI-1 via binding to its 3'-UTR in OS cells. CONCLUSION: miR-218 can promote OS cell apoptosis and plays the role as a tumor suppressor by down-regulating BMI-1.


Assuntos
Apoptose , Neoplasias Ósseas/metabolismo , MicroRNAs/metabolismo , Vírus da Leucemia Murina de Moloney/metabolismo , Osteossarcoma/metabolismo , Complexo Repressor Polycomb 1/metabolismo , Proteínas Proto-Oncogênicas/metabolismo , Animais , Neoplasias Ósseas/patologia , Linhagem Celular Tumoral , Proliferação de Células , Sobrevivência Celular , Regulação Neoplásica da Expressão Gênica , Camundongos , Osteossarcoma/patologia , Poli(ADP-Ribose) Polimerases/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...